Author:
Mennini F. S.,Marcellusi A.,Arduini E.,Mauro G.,Mecozzi A.,Tuzi A.,Cortesi E.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Health Policy
Reference19 articles.
1. Ferlay J, Autier P, Boniol M, et al. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007; 18: 581–92
2. Rosso S, Spitale A, Balzi D, et al. Estimate of cancer incidence in Italian regions, 2001. Epidemiol Prev 2004; 28: 247–57
3. Zanetti R, Falcini F, Simonato L, et al. Survival of cancer patients in Italy in the nineties: the importance of population based data. Epidemiol Prev 2001; 25 (3 Suppl): 1–8
4. Barni S, Venturini M, Beretta GD, et al. Agreement between oncology guidelines and clinical practice in Italy: the ‘right’ program. A project of the Italian Association of Medical Oncology (AIOM). Ann Oncol 2007; 18 Suppl 6: 179–84
5. Ducreux M, Bennouna J, Hebbar M, et al. Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX-6) as first-line treatment for metastatic colorectal cancer. Int J Cancer 2011; 128: 682–90
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献